Actively Recruiting
VIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures
Led by Istituto Oncologico Veneto IRCCS · Updated on 2026-01-13
56
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Though the efficacy of VRH is documented in various outpatient urological procedures and has provided promising preliminary information in prostate biopsy, its systematic use in urology remains poorly studied. Considering the potential of invasive urological procedures to induce significant patient discomfort, the application of innovative immersive approaches, such as those offered by medical devices, could lead to an overall clinical benefit. Among these, REALICA® (available from https://REALICA.io/en/), a class I CE medical device, widely used in hospitals and validated by numerous studies, represents a valuable resource in urology, supported by high satisfaction rates received in abdominal surgery and extracorporeal lithotripsy
CONDITIONS
Official Title
VIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18 years or older
- Undergoing one of the specified urological procedures for the first time
- Eligible for minimally invasive outpatient urological procedures such as circumcision, prostate biopsy, or flexible cystoscopy
- Able to understand instructions and complete study questionnaires
- Signed informed consent
You will not qualify if you...
- Absolute contraindications to planned urological procedure (e.g., active urinary tract infection, urethral abnormalities)
- Recent urological procedures like urethral dilation, bladder biopsy, or stent insertion/removal
- Medical issues preventing virtual reality use, including uncontrolled photosensitive epilepsy and significant neurological, eye, or ear disorders
- Severe psychiatric disorders or major cardiovascular diseases interfering with participation
- Previous adverse reactions to virtual reality
- Use of analgesic medications within 24 hours before procedure
- Use of drugs affecting consciousness or ability to complete psychological assessments
- Severe communication disabilities or hearing impairment preventing questionnaire completion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istituto Oncologico Veneto IRCCS
Padova, Italy, 35128
Actively Recruiting
Research Team
A
Antonio Amodeo, MD
CONTACT
G
Gian Luca De Salvo, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here